Treatment policy change to dihydroartemisinin–piperaquine contributes to the reduction of adverse maternal and pregnancy outcomes

BACKGROUND: In Papua, Indonesia, maternal malaria is prevalent, multidrug resistant and associated with adverse outcomes for mother and baby. In March 2006, anti-malarial policy was revised for the second and third trimester of pregnancy to dihydroartemisinin–piperaquine (DHP) for all species of mal...

Descripción completa

Detalles Bibliográficos
Autores principales: Poespoprodjo, Jeanne Rini, Fobia, Wendelina, Kenangalem, Enny, Lampah, Daniel A, Sugiarto, Paulus, Tjitra, Emiliana, Anstey, Nicholas M, Price, Richard N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4501192/
https://www.ncbi.nlm.nih.gov/pubmed/26169783
http://dx.doi.org/10.1186/s12936-015-0794-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4501192/
https://www.ncbi.nlm.nih.gov/pubmed/26169783
http://dx.doi.org/10.1186/s12936-015-0794-0

Ejemplares similares